Bacteraemia in cancer and transplant patients may be caused by opportunistic organisms including environmental contaminants (Krzywda & Edmiston, 2002) . We report what we believe to be the first case of bacteraemia caused by the environmental bacterium Asaia lannaensis and discuss its possible sources, including a central venous catheter (CVC), and review relevant literature.
A 3-year-old Caucasian boy with medulloblastoma in relapse, who had received an autologous haematopoietic stem cell transplant (AHSCT), underwent chemotherapy and craniospinal radiation followed by a second AHSCT. The patient received a preparative chemotherapy regimen of carboplatin, etoposide and melphalan followed by the AHSCT at a CD34+ dose of 3.73610 6 cells kg 21 . His post-transplant course was complicated by severe mucositis, pancytopenia and Clostridium difficile colitis diagnosed on day 6 post-transplantation (PT). He was successfully treated for the C. difficile colitis with metronidazole. On day 7, he developed hypertonia and spastic posturing. Magnetic resonance imaging of the brain showed an old subdural haematoma and possible radiation necrosis in the brainstem. He underwent craniotomy and drainage of the haematoma, and was treated with intravenous meropenem and vancomycin because of the neutropenia and mucositis. He improved and engrafted by day 12 PT. His antibiotic treatment was changed to intravenous cefepime. On day 14 PT, he developed tachycardia, hypotension and fever up to 40.1 u C. Blood cultures were obtained from both lumens of the CVC. Intravenous meropenem and vancomycin were restarted. Both blood cultures grew Gram-negative bacilli within 12-18 h. The patient remained febrile and hypotensive and tobramycin was added to his treatment regimen. Because the CVC was a possible source of infection, the catheter was locked with 70 % ethanol (the catheter volume plus 0.1 ml) according to our institutional protocol for sterilizing CVCs without removal. After 24 h, the catheter was flushed with normal saline (Dannenberg et al., 2003; Onland et al., 2006) .
Phenotypic methods misidentified or failed to identify the Gram-negative bacillus recovered from blood cultures. The organism exhibited high MICs for all antibiotics tested except gentamicin, tobramycin and tigecycline (Table 1) . Meropenem was discontinued and the patient was treated with tobramycin for 14 days. Repeat blood cultures were negative. The patient showed progressive clinical improvement and was discharged from the hospital on day 36 PT. The organism was identified by 16s rRNA gene sequencing as A. lannaensis. The patient had no recurrence of infection during the subsequent several weeks.
The two sets of blood cultures obtained at the onset of fever on day 14 PT were incubated in an automated blood culture system (Bactec 9240; Becton Dickinson). After 12.5 and 27.2 h of incubation, the aerobic bottles grew a Gram-negative bacillus of variable length. The isolate was subcultured onto chocolate, blood and MacConkey aerobic agars and Columbia anaerobic blood agar. Small, pale rosecoloured colonies were detected on the blood and chocolate agars after overnight incubation at 35 u C in a 5-8 % CO 2 atmosphere. The organism was motile, non-haemolytic, non-fermentative, oxidase-negative and catalase-positive. Tiny colonies appeared on the MacConkey plate, but only after 72 h of incubation.
Two commercial identification systems failed to identify the organism. The organism did not grow for identification and susceptibility testing in the MicroScan WalkAway 9600 (Siemens Healthcare Diagnostics). The organism grew in the API 20 NE and 20 E panels (bioMérieux) with the former unable to identify the organism and the latter identifying it as Acinetobacter baumannii. This was improbable because of the Gram-stain morphology, colony pigmentation, growth requirements and also the colistin resistance, which had not yet been seen in Acinetobacter baumannii in our hospital. Antibiotic susceptibility of the clinical isolate was determined using the Etest gradient agar diffusion methodology (AB Biodisk).
Molecular identification of Asaia was performed by 16S rRNA gene sequencing using the MicroSeq Bacterial Identification kit (PE Applied Biosystems) according to the manufacturer's instructions. The sequence was subjected to BLAST analysis at the NCBI website and showed 100 % concordance with A. lannaensis (AB286051.1). To our knowledge, this is the first case of human disease caused by A. lannaensis.
Asaia is a recently described genus that contains three members, Asaia bogorensis, Asaia siamensis and Asaia krungthepensis, which were first isolated from flowers and fermented glutinous rice in Indonesia and Thailand (Katsura et al., 2001; Yamada et al., 2000; Yukphan et al., 2004) . A. lannaensis was more recently isolated from the flowers of the spider lily collected in Thailand (Malimas et al., 2008) . Three previously reported cases of invasive human infections with Asaia were all caused by A. bogorensis (Snyder et al., 2004; Tuuminen et al., 2006 Tuuminen et al., , 2007 . The first was in a 41-year-old diabetic woman with end stage renal disease, on peritoneal dialysis, who developed refractory peritonitis and possible sepsis with a Gram-negative rod despite prolonged treatment with cefepime and ampicillin/sulbactam. She was treated with intravenous tobramycin and imipenem but required removal of the dialysis catheter (Snyder et al., 2004) . The second case was in a 23-year-old man with a history of intravenous drug use who had Hill-Ewing sarcoma that required resection and knee prosthesis placement. His course was complicated by chronic enterococcal arthritis requiring prolonged treatment with amoxicillin/clavulanate and clindamycin. He then developed A. bogorensis bacteraemia, which was successfully treated with intravenous tobramycin and ceftriaxone based on susceptibility testing results (Tuuminen et al., 2006) . The third case was in a 20-year old drug abuser who had fever and a blood culture positive for A. bogorensis (Tuuminen et al., 2007) . Contamination of narcotic substances was postulated to be the source of bacteraemia in the latter two cases (Tuuminen et al., 2006 (Tuuminen et al., , 2007 .
Asaia species grow well at low pH (3.0) and at 30 u C. They grow slowly at 34 u C, but are said to be unable to grow at 37 u C, which may explain the rarity of human infections caused by this bacterium (Katsura et al., 2001; Yamada et al., 2000) . As in previous reports, the Asaia species from our patient was not identified by routine laboratory testing but by 16S rRNA gene sequencing (Moore et al., 2002; Snyder et al., 2004; Tuuminen et al., 2006) . This illustrates the importance of using molecular methods such as 16S rRNA gene sequencing for correct identification of bacterial species when commercial methods fail.
Because Asaia species have not been recognized as human pathogens, there are no interpretative breakpoints for susceptibility testing. Consistent with previous reports, our isolate did not grow in Mueller-Hinton broth (Moore et al., 2002; Tuuminen et al., 2006) , which is used by the MicroScan for susceptibility testing by microbroth dilution. However, it grew on chocolate and blood agars, which allowed susceptibility determination by Etest. Like previous A. bogorensis isolates, the A. lannaensis from our patient showed high MIC levels for almost all antibiotics that are used to treat Gramnegative rods including penicillins, cephalosporins, aztreonam, fluoroquinolones, carbapenems and amikacin, suggesting resistance to these antibiotics (Table 1) . However, gentamicin and tobramycin MICs were within the range interpreted as susceptible for nonfermentative Gram-negative bacilli (CLSI, 2008) . Our patient was treated with intravenous tobramycin.
The source of infection in our patient is unknown. Given his underlying condition, he had no flowers and plants in his room. Our patient had mucositis, C. difficile colitis and a tunnelled CVC, any of which could have contributed to his acquisition of the infection. The exit site of the CVC was slightly erythematous and indurated but was not painful and exhibited no discharge. The CVC was locked with ethanol, which has previously been found to be a safe and effective method for decontamination and retention of infected CVCs (Dannenberg et al., 2003; Onland et al., 2006) . Because it was not removed, 
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